Augmedix, Inc.

Augmedix, Inc.

Augmedix, Inc.

Date Founded



1161 Mission Street,Suite 210,San Francisco, CA 94103

Type of Company


Employees (Worldwide)

251 - 500


Computer Software
Hospitals & Patient Services
Retail: Appliances & Electronics
Holding Companies
Medical Support Services

Company Description

Augmedix, Inc. provides technology-enabled documentation services for health systems and doctors. It offers electronic health records that re-humanize the doctor-patient relationship, and address the largest pain-point healthcare system - the burden of documentation. The company was founded by Ian Shakil and Pelu Tran in 2012 and is headquartered in San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at Augmedix, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Executive Officer, Co-Founder




Head of Analytics & Insights

Head of Design

Head of Clinical Operations

Global Head of Operations

Head of Compliance

Board of Directors

General Partner at Doll Capital Management, Inc.

General Partner at Emergence Capital Partners

Managing Director, Redmile Group at Scanadu, Inc.

Co-Founder at Augmedix, Inc.

Chief Executive Officer, Co-Founder at Augmedix, Inc.

Paths to Augmedix, Inc.
Potential Connections via
Relationship Science
Augmedix, Inc.
Advisors & Consultants
Senior Advisor

Managing Director at Alta Partners Management Corp.

Details Hidden

Redmile Group invests primarily in U.S. and non-U.S. healthcare companies. While the partnerships and funds generally invest in public equities, these investtments may be in illiquid, publicly-quoted securities, investments may be made in illiquid, publicly-quoted securities. The partnerships or funds may invest in private companies and non-equity asset classes when Redmile Group believes such investments offer a superior risk-reward. The firm may also invest in fields related to healthcare where due diligence shows that the healthcare assets are the driving force behind value creation and may also invest in other sectors from time to time.While Redmile Group mainly invests public equities of healthcare companies, they gennerally have broad and flexible investment authority. To maintain flexibility and capitalize on investment opportunities as they arise, the Redmile Group isn't required to invest any particular percentage of managed portfolios in any particular type of investment or region, and the amount of the portfolios which is invested in any type of investment or which is weighted in different countries or different sectors can change at any time. As such, investments may at any time include long or short positions in U.S. or non-U.S. publicly traded or privately issued common stocks, preferred stocks, stock warrants and rights, bonds, notes or other debentures or debt participations, convertible bonds, convertible preference shares, fund interests, swaps, options (including options on stock market indices), futures contracts, commodities, forward contracts and other securities or financial instruments including those of investment companies.^

Details Hidden

OrbiMed focuses exclusively on global investments across the entire spectrum of private and publicly-traded life sciences companies. They seek to invest in the most promising investment opportunities regardless of a company's stage of development. The firm invests at all stages of development from private start-ups and university spinouts to the largest global pharmaceutical companies. OrbiMed focuses on companies involved in drug development, drug discovery and medical devices, with particular emphasis on mid-stage private companies. Investments typically range from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role on their portfolio companies' boards of directors

Details Hidden

Mckesson Ventures partners with companies that are enabling and driving positive change while pursuing high-growth opportunities. The firm invests in healthcare companies and provides financing for early and growth stage capital requirements.Mckesson Ventures acquires minority interests in the portfolio companies.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Augmedix, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Augmedix, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Augmedix, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15